Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Adamis Pharmaceuticals Corporation

ADMP•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.78
$0.007(0.85%)
U.S. Market is Open • 12:57

Adamis Pharmaceuticals Corporation (ADMP) Stock Overview

Explore Adamis Pharmaceuticals Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.3M
P/E Ratio-0.06
EPS (TTM)$-10.14
ROE-2.09%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ADMP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Adamis Pharmaceuticals Corporation (ADMP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.06 and a market capitalization of 7.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
19.03%
1-Month Change
-0.01%
3-Month Change
-63.95%
6-Month Change
-88.94%
Year-to-Date (YTD) Change
-93.30%
1-Year Change
-91.44%
3-Year Change
-98.67%
5-Year Change
-99.64%
All-Time (Max) Change
-100.00%

Contact Information

https://www.adamispharmaceuticals.com
858 997 2400
11682 El Camino Real, San Diego, CA, 92130

Company Facts

110 Employees
IPO DateAug 14, 1995
CountryUS

Frequently Asked Questions